Reversible posterior leuko-encephalopathy in children with sickle cell disease

Pediatric Blood and Cancer

Volumn 52, Issue 3, 2009, Pages 373-375

  Khademian, Zarir ^a   Speller Brown, Barbara ^b   Nouraie, Seyed Medhi ^c   Minniti, Caterina P ^d  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^c HOWARD UNIVERSITY   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Hemoglobinopathies; Neurology and sickle cell; Sickle cell disease

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ADOLESCENT; ARTICLE; BRAIN DISEASE; CHILD; CLINICAL FEATURE; FEMALE; FOLLOW UP; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SICKLE CELL ANEMIA; RADIOGRAPHY;

ADOLESCENT; ANEMIA, SICKLE CELL; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; POSTERIOR LEUKOENCEPHALOPATHY SYNDROME;

EID: 58949088344     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21812     Document Type: Article

References (15)

1. Ohene FK, Weiner SJ, Sleeper LA, et al. Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood 1998;91:288-294.
2. Miller ST, Macklin EA, Pegelow CH, et al. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: A report from the Cooperative Study of Sickle Cell Disease. J Pediatr 2001;138:385-390.
3. Switzer J, Hess D, Nichols F, et al. Pathophysiology and treatment of stroke in sickle-cell disease: Present and future. Lancet Neurol 2006;5:501-512.
4. Mukherjee P, McKinstry RC. Reversible posterior leukoencephal- opathy syndrome: Evaluation with diffusion-tensor MR imaging. Radiology 2001;219:756-765.
5. Hinchey J, Chaves C, Appignoni B, et al. A reversible posterior leukoencephalopathy syndrome. NEJH 1996;334:494-500.
6. Schwartz R, Eaton J, Arnoldus E, et al. Correspondences: A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996;334:1743-1745.
7. Stott V, Hurrell M, Anderson T, Reversible posterior leukoence-phalopathy syndrome: A misnomer reviewed. Intern Med J 2005; 35:83-90.
8. Lamy C, Oppenheim C, Meder J, et al. Neuroimaging in posterior reversible encephalopathy syndrome. J Neuroimaging 2004;14: 89-969.
9. Prasad N, Gulati S, Gupta K, et al. Spectrum of radiological changes in hypertensive children with reversible posterior leucoencephalopathy. Br J Radiol 80:2007;422-429.
10. Norman J, Parke J, Wilson D, et al. Reversible leukoencephalop- athy syndrome in children undergoing induction therapy for acute lymphoblastic leukemia. Pediatr Blood Cancer 2007;49:198-203.
11. Henderson J, Noetzel M, McKinstry R, et al. Reversible posterior leukoencephalopathy syndrome and silent cerebral infarcts are associated with severe acute chest syndrome in children with sickle cell disease. Blood 2003;101:415-419.
12. Rodgers GP, Walker EC, Podgor MJ. Is, "relative" hypertension a risk factor for vaso-occlusive complications in sickle cell disease? Am J Med Sci 1993;305:150-156.
13. Pegelow CH, Colangelo L, Steinberg M, et al. Natural history of blood pressure in sickle cell disease: Risks for stroke and death associated with relative hypertension in sickle cell anemia. Am J Med 1997;102:171-177.
14. Darbari D, Castro O, Taylor VIJ, et al. Severe vaso-occlusive Episodes associated with use of systemic corticosteroids in patients with sickle cell disease. J National Med Assoc 2008;100:948.
15. Rackoff W, Ohene Franpong K, Month S, et al. Neurologic events after partial exchange transfusion for priapism in sickle cell disease. J Pediatrics 2002;120:882.